| NCT03408964 |
Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients |
https://ClinicalTrials.gov/show/NCT03408964 |
Recruiting |
Oncology Institute of Southern Switzerland |
2020-12-31 |
| NCT03383107 |
Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local Microbiome |
https://ClinicalTrials.gov/show/NCT03383107 |
Recruiting |
Weill Medical College of Cornell University |
2021-01-31 |
| NCT03383016 |
Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE) |
https://ClinicalTrials.gov/show/NCT03383016 |
Recruiting |
CHU de Quebec-Universite Laval |
2020-08-31 |
| NCT03382522 |
Prognostic Value of SPECT-CT Quantitative Indices for the Response Assessment of Bone Metastatic Prostate Carcinoma |
https://ClinicalTrials.gov/show/NCT03382522 |
Completed |
University Hospital, Brest |
2018-03-30 |
| NCT03381326 |
CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC. |
https://ClinicalTrials.gov/show/NCT03381326 |
Active, not recruiting |
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
2019-10-31 |
| NCT03381105 |
From PSA to Stockholm3: Study Part 1 |
https://ClinicalTrials.gov/show/NCT03381105 |
Active, not recruiting |
Helse Stavanger HF |
2020-12-31 |
| NCT03376360 |
Functional Medical Imaging Quantization in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03376360 |
Completed |
University Hospital, Brest |
2017-05-01 |
| NCT03368989 |
The Effects of Radium-223 Dichloride Therapy on Radionuclide Bone Scan Lesions. |
https://ClinicalTrials.gov/show/NCT03368989 |
Completed |
The University of Texas Health Science Center, Houston |
2017-02-07 |
| NCT03331068 |
French Validation of the Memorial Anxiety Scale for Patients With Prostate Cancer. |
https://ClinicalTrials.gov/show/NCT03331068 |
Completed |
Institut Paoli-Calmettes |
2017-11-01 |
| NCT03328364 |
A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden |
https://ClinicalTrials.gov/show/NCT03328364 |
Completed |
Astellas Pharma Inc |
2017-12-24 |
| NCT03247010 |
Bone Marrow Suppression and Recovery During Radionuclide Treatment |
https://ClinicalTrials.gov/show/NCT03247010 |
Active, not recruiting |
Rigshospitalet, Denmark |
2019-10-01 |
| NCT03236688 |
Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP) |
https://ClinicalTrials.gov/show/NCT03236688 |
Active, not recruiting |
Exosome Diagnostics, Inc. |
2020-02-29 |
| NCT03237026 |
Decipher the Biology of Lethal Prostate Cancer—Urine Metabolomics Profiles for Predictive/Prognostic Markers in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03237026 |
Recruiting |
National Taiwan University Hospital |
2021-07-31 |
| NCT03228810 |
Genetic Biomarker Discovery for Metastatic Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03228810 |
Completed |
Mayo Clinic |
2019-04-09 |
| NCT03213951 |
Ex-vivo Investigation of Beta Probe for Prostate Cancer Resection and Evaluation of PSMA-PET for Diagnosis of Intraprostatic Lesions |
https://ClinicalTrials.gov/show/NCT03213951 |
Completed |
Indiana University |
2019-11-13 |
| NCT03214315 |
Structural Network on Prostate Cancer in the French Greater West Region |
https://ClinicalTrials.gov/show/NCT03214315 |
Completed |
University Hospital, Tours |
2016-09-27 |
| NCT03209492 |
Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for “Prostate Cancer” |
https://ClinicalTrials.gov/show/NCT03209492 |
Completed |
Takeda |
2017-12-01 |
| NCT03194516 |
Ketogenic Diet and Prostate Cancer Surveillance Pilot |
https://ClinicalTrials.gov/show/NCT03194516 |
Active, not recruiting |
University of Maryland, Baltimore |
2019-11-01 |
| NCT03193645 |
Observational Prospective Study Describing the Global Patient Care and Follow-up of Prostate Cancer Patients Treated With Degarelix |
https://ClinicalTrials.gov/show/NCT03193645 |
Completed |
Ferring Pharmaceuticals |
2018-06-30 |
| NCT03193060 |
A Multi-centre, Prospective, Observational Study on Effectiveness and Safety of ZOLADEX® (Goserelin Acetate Implant) 10.8 mg and ZOLADEX® (Goserelin Acetate Implant) 3.6 mg in Chinese Patients With Localized or Locally Advanced Hormonal Treatment -naïve Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03193060 |
Completed |
AstraZeneca |
2019-12-27 |
| NCT03176381 |
Tissue Predictors of Abiraterone Benefit |
https://ClinicalTrials.gov/show/NCT03176381 |
Recruiting |
Tianjin Medical University Second Hospital |
2019-05-05 |
| NCT03177759 |
Living With Prostate Cancer (LPC) |
https://ClinicalTrials.gov/show/NCT03177759 |
Completed |
Vancouver Prostate Centre |
2019-06-30 |
| NCT03177551 |
Predictive Nomogram of CRPC |
https://ClinicalTrials.gov/show/NCT03177551 |
Recruiting |
Tianjin Medical University Second Hospital |
2019-09-30 |
| NCT03162003 |
Irish Programme for Stratified Prostate Cancer Therapy |
https://ClinicalTrials.gov/show/NCT03162003 |
Active, not recruiting |
Cancer Trials Ireland |
2024-02-29 |
| NCT03158922 |
The BARCODE 1 Study |
https://ClinicalTrials.gov/show/NCT03158922 |
Active, not recruiting |
Institute of Cancer Research, United Kingdom |
2018-04-14 |
| NCT03159676 |
Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03159676 |
Active, not recruiting |
Mayo Clinic |
2021-06-30 |
| NCT03151356 |
Prostate Health Index for Prostate Cancer Diagnosis |
https://ClinicalTrials.gov/show/NCT03151356 |
Completed |
Hospices Civils de Lyon |
2018-09-19 |
| NCT03133286 |
Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) |
https://ClinicalTrials.gov/show/NCT03133286 |
Recruiting |
DxTerity Diagnostics |
2019-09-06 |
| NCT03128710 |
Prostate Cancer Survey |
https://ClinicalTrials.gov/show/NCT03128710 |
Active, not recruiting |
University of Maryland, Baltimore |
2020-12-31 |
| NCT03122743 |
Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03122743 |
Active, not recruiting |
Wake Forest University Health Sciences |
2020-10-31 |
| NCT03091231 |
Multiparametric Ultrasound-Study for the Detection of Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03091231 |
Completed |
Martini-Klinik am UKE GmbH |
2017-12-31 |
| NCT03082274 |
Prospective Validation of Prostate Biomarkers for Repeat Biopsy |
https://ClinicalTrials.gov/show/NCT03082274 |
Enrolling by invitation |
MDx Health |
2019-12-30 |
| NCT03034187 |
Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate |
https://ClinicalTrials.gov/show/NCT03034187 |
Recruiting |
University Medical Center Groningen |
2025-01-31 |
| NCT03031418 |
Clinical Evaluation of the ‘ExoDx Prostate IntelliScore’ (EPI) |
https://ClinicalTrials.gov/show/NCT03031418 |
Recruiting |
Exosome Diagnostics, Inc. |
2020-02-01 |
| NCT03017794 |
Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy in Prostate Carcinoma |
https://ClinicalTrials.gov/show/NCT03017794 |
Recruiting |
Mayo Clinic |
2020-12-31 |
| NCT03017313 |
To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients |
https://ClinicalTrials.gov/show/NCT03017313 |
Active, not recruiting |
Ipsen |
2019-12-11 |
| NCT03009123 |
Will Erectile Dysfunction Increase the Risk of Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03009123 |
Completed |
Kuang Tien General Hospital |
2017-03-15 |
| NCT02997709 |
Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients |
https://ClinicalTrials.gov/show/NCT02997709 |
Recruiting |
University of Miami |
2023-06-30 |
| NCT02998619 |
Radiotherapy of Pelvic Lymph Nodes in High Risk Prostate Cancer - A Retrospective Analysis |
https://ClinicalTrials.gov/show/NCT02998619 |
Completed |
Kantonsspital Graubuenden |
2017-11-11 |
| NCT02991794 |
Prostatectomies Using Einstein Vision® 3D |
https://ClinicalTrials.gov/show/NCT02991794 |
Active, not recruiting |
Aesculap AG |
2019-12-31 |
| NCT02974231 |
Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02974231 |
Completed |
Institut de Cancérologie de Lorraine |
2015-03-31 |
| NCT02963675 |
Incidence of Second Primary Malignancies in Prostate Cancer Patients With Bone Metastases - an Observational Retrospective Cohort Study in Sweden |
https://ClinicalTrials.gov/show/NCT02963675 |
Completed |
Bayer |
2017-03-31 |
| NCT02941029 |
RADTOX: Measuring Radiation Toxicity Using Circulating DNA |
https://ClinicalTrials.gov/show/NCT02941029 |
Completed |
University of Florida |
2017-03-31 |
| NCT02940977 |
Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique |
https://ClinicalTrials.gov/show/NCT02940977 |
Recruiting |
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
2019-03-30 |
| NCT02925702 |
PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223. |
https://ClinicalTrials.gov/show/NCT02925702 |
Active, not recruiting |
Centro Nacional de Investigaciones Oncologicas CARLOS III |
2019-01-31 |
| NCT02922218 |
PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide. |
https://ClinicalTrials.gov/show/NCT02922218 |
Active, not recruiting |
Centro Nacional de Investigaciones Oncologicas CARLOS III |
2020-01-31 |
| NCT02919904 |
Feasibility Study for the Assessment of Sleep Quality in Men With Prostate Cancer Starting ADT |
https://ClinicalTrials.gov/show/NCT02919904 |
Completed |
Vancouver Prostate Centre |
2018-09-30 |
| NCT02899312 |
PSMA PET/CT for Assessment of Recurrent Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02899312 |
Recruiting |
British Columbia Cancer Agency |
2021-09-30 |
| NCT02899104 |
Navigant Study- Treatment Patterns in mCRPC (Metastatic Castrate Resistant Prostate Cancer ) |
https://ClinicalTrials.gov/show/NCT02899104 |
Completed |
Bayer |
2019-03-31 |
| NCT02882178 |
Formal Consensus Method to Evaluate the Conformity of Prescription of a Recently Approved Chemotherapy Treatment in an Observatory Study |
https://ClinicalTrials.gov/show/NCT02882178 |
Completed |
Institut Bergonié |
2015-04-30 |
| NCT02886598 |
Safety and Efficacy of Firmagon® (Degarelix) for Injection |
https://ClinicalTrials.gov/show/NCT02886598 |
Completed |
Ferring Pharmaceuticals |
2019-03-26 |
| NCT02873117 |
Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers |
https://ClinicalTrials.gov/show/NCT02873117 |
Completed |
Rennes University Hospital |
2016-12-31 |
| NCT02873013 |
Asia Study Group of Prostate Cancer (A-CaP Study) |
https://ClinicalTrials.gov/show/NCT02873013 |
Enrolling by invitation |
Japan Study Group of Prostate Cancer |
2019-03-31 |
| NCT02856100 |
Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02856100 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2019-01-31 |
| NCT02854982 |
Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02854982 |
Completed |
Centre Hospitalier Universitaire de NÄ«mes |
2018-01-01 |
| NCT02853097 |
Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients |
https://ClinicalTrials.gov/show/NCT02853097 |
Recruiting |
University of Southern California |
2020-06-14 |
| NCT02853409 |
Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02853409 |
Completed |
Ipsen |
2015-12-31 |
| NCT02825875 |
Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02825875 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2020-04-30 |
| NCT02813408 |
A Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer Participants |
https://ClinicalTrials.gov/show/NCT02813408 |
Completed |
Janssen Pharmaceutica N.V., Belgium |
2018-03-21 |
| NCT02816983 |
SBRT for Oligometastatic Castration-Refractory Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02816983 |
Active, not recruiting |
Mayo Clinic |
2020-08-31 |
| NCT02803086 |
Longitudinal Evaluation of Intestinal, Haematological and Urinary Toxicity From Pelvic Irradiation for Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02803086 |
Recruiting |
IRCCS San Raffaele |
2020-12-31 |
| NCT02793882 |
Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02793882 |
Completed |
Sir Mortimer B. Davis - Jewish General Hospital |
2017-03-25 |
| NCT02788409 |
Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US |
https://ClinicalTrials.gov/show/NCT02788409 |
Completed |
Bayer |
2018-05-09 |
| NCT02787837 |
PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate. |
https://ClinicalTrials.gov/show/NCT02787837 |
Active, not recruiting |
Centro Nacional de Investigaciones Oncologicas CARLOS III |
2018-04-30 |
| NCT02761135 |
Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique? |
https://ClinicalTrials.gov/show/NCT02761135 |
Completed |
Kronoberg County Council |
2018-03-31 |
| NCT02729103 |
Treatment Patterns in Metastatic Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02729103 |
Completed |
Bayer |
2017-01-19 |
| NCT02723734 |
Validation Study on the Impact of Decipher® Testing - VANDAAM Study |
https://ClinicalTrials.gov/show/NCT02723734 |
Recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2021-04-30 |
| NCT02705846 |
Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations |
https://ClinicalTrials.gov/show/NCT02705846 |
Recruiting |
Institute of Cancer Research, United Kingdom |
2020-12-31 |
| NCT02702908 |
Second Primary Cancers in Patients With Castration Resistant Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02702908 |
Completed |
Bayer |
2017-10-20 |
| NCT02702856 |
Clinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02702856 |
Completed |
Exosome Diagnostics, Inc. |
2015-04-30 |
| NCT02689271 |
CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancEr |
https://ClinicalTrials.gov/show/NCT02689271 |
Completed |
University College, London |
2019-12-31 |
| NCT02677376 |
Imaging Biomarkers to Validate Response in Enzalutamide-Treated mCRPC |
https://ClinicalTrials.gov/show/NCT02677376 |
Completed |
University of Wisconsin, Madison |
2018-03-30 |
| NCT02669771 |
Long-Term Specified Drug Use-Results Survey for Xtandi Capsule |
https://ClinicalTrials.gov/show/NCT02669771 |
Completed |
Astellas Pharma Inc |
2018-11-30 |
| NCT02669147 |
A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPC |
https://ClinicalTrials.gov/show/NCT02669147 |
Active, not recruiting |
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan |
2021-03-31 |
| NCT02663193 |
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability |
https://ClinicalTrials.gov/show/NCT02663193 |
Completed |
Janssen Scientific Affairs, LLC |
2017-01-31 |
| NCT02657863 |
Cancer DNA Detection in Blood and Urine |
https://ClinicalTrials.gov/show/NCT02657863 |
Active, not recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2020-11-30 |
| NCT02652000 |
Quality of Life After Permanent Interstitial Iodine Seed Prostate Brachytherapy |
https://ClinicalTrials.gov/show/NCT02652000 |
Completed |
Kantonsspital Graubuenden |
2016-12-31 |
| NCT02630641 |
Perception of Cohesion Within a Relationship (Dyadic Adjustment) on the Quality of Life of Patients With Prostate Cancer With Gonadotropin-releasing Hormone. |
https://ClinicalTrials.gov/show/NCT02630641 |
Completed |
Ipsen |
2017-11-30 |
| NCT02608359 |
A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02608359 |
Recruiting |
Johnson & Johnson Private Limited |
2021-11-30 |
| NCT02573636 |
The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients With Biochemical Failure Status Post Salvage or Radical Radiation Therapy |
https://ClinicalTrials.gov/show/NCT02573636 |
Recruiting |
Sir Mortimer B. Davis - Jewish General Hospital |
2022-01-31 |
| NCT02981797 |
Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223 |
https://ClinicalTrials.gov/show/NCT02981797 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2017-08-29 |
| NCT02380274 |
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC) |
https://ClinicalTrials.gov/show/NCT02380274 |
Active, not recruiting |
Astellas Pharma Inc |
2021-04-30 |
| NCT02564120 |
North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) |
https://ClinicalTrials.gov/show/NCT02564120 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2018-12-31 |
| NCT02562131 |
PET-MR-PSA Prostate Cancer Recidive Study |
https://ClinicalTrials.gov/show/NCT02562131 |
Active, not recruiting |
Norwegian University of Science and Technology |
2027-12-31 |
| NCT00342771 |
An Epidemiological Study of Genetic Risk Factors for Prostate Cancer in African-American and Caucasian Males |
https://ClinicalTrials.gov/show/NCT00342771 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02543905 |
The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment |
https://ClinicalTrials.gov/show/NCT02543905 |
Recruiting |
Institute of Cancer Research, United Kingdom |
2021-02-28 |
| NCT02542501 |
Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues |
https://ClinicalTrials.gov/show/NCT02542501 |
Completed |
Ipsen |
2018-07-21 |
| NCT02526797 |
Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance |
https://ClinicalTrials.gov/show/NCT02526797 |
Enrolling by invitation |
Herlev Hospital |
2020-07-31 |
| NCT02526589 |
Does Bloody Urine Predict Urethrovesical Anastomosis Leakage After Radical Prostatectomy |
https://ClinicalTrials.gov/show/NCT02526589 |
Completed |
Tampere University Hospital |
2017-09-20 |
| NCT02518698 |
Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population |
https://ClinicalTrials.gov/show/NCT02518698 |
Completed |
Bayer |
2017-09-30 |
| NCT02512185 |
Towards Optimal Prescription of Chemotherapy in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02512185 |
Recruiting |
University Health Network, Toronto |
2019-12-31 |
| NCT02495974 |
European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC) |
https://ClinicalTrials.gov/show/NCT02495974 |
Completed |
Astellas Pharma Inc |
2019-02-08 |
| NCT02471469 |
Personalizing Enzalutamide Therapy by Understanding the Relation Between Tumor mRNAs, miRNAs and Treatment Response |
https://ClinicalTrials.gov/show/NCT02471469 |
Completed |
Radboud University |
2019-02-13 |
| NCT02462447 |
Carbon-11 Labeled Sarcosine in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02462447 |
Completed |
University of Michigan |
2017-02-08 |
| NCT02456571 |
CTC Immune Checkpoint |
https://ClinicalTrials.gov/show/NCT02456571 |
Completed |
Duke University |
2019-06-13 |
| NCT02450812 |
Non-interventional Study With Ra-223 Dichloride Assessing Overall Survival and Effectiveness Predictors for mCRPC Patients in a Real Life Setting in Germany |
https://ClinicalTrials.gov/show/NCT02450812 |
Active, not recruiting |
Bayer |
2020-06-01 |
| NCT02443571 |
Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC) |
https://ClinicalTrials.gov/show/NCT02443571 |
Completed |
Blue Earth Diagnostics |
2015-06-30 |
| NCT03386812 |
Investigating Bone and Skeletal Muscle Interaction in Men With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03386812 |
Active, not recruiting |
University of Texas Southwestern Medical Center |
2020-10-01 |
| NCT02432001 |
Radiologically Guided Biopsies of mCRPC |
https://ClinicalTrials.gov/show/NCT02432001 |
Active, not recruiting |
University of California, San Francisco |
2020-01-01 |
| NCT02426333 |
Optimizing Abiraterone Therapy |
https://ClinicalTrials.gov/show/NCT02426333 |
Completed |
Radboud University |
2019-04-24 |
| NCT02425800 |
Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells |
https://ClinicalTrials.gov/show/NCT02425800 |
Completed |
Wake Forest University Health Sciences |
2018-11-05 |
| NCT02424448 |
Study to Determine the Feasibility, Evaluability and Variability in Markers of Drug Action in Castration Resistant Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02424448 |
Completed |
The Christie NHS Foundation Trust |
2016-07-31 |
| NCT02425592 |
Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE) |
https://ClinicalTrials.gov/show/NCT02425592 |
Recruiting |
Yale University |
2020-05-31 |
| NCT02414971 |
Relationship of Mitochondrial Enzymes With Cancer Related Fatigue |
https://ClinicalTrials.gov/show/NCT02414971 |
Completed |
University of Florida |
2019-01-14 |
| NCT02410044 |
Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02410044 |
Active, not recruiting |
iOMEDICO AG |
2019-08-16 |
| NCT02397629 |
Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer Diagnosis |
https://ClinicalTrials.gov/show/NCT02397629 |
Completed |
Wake Forest University Health Sciences |
2016-05-31 |
| NCT02398526 |
Pain Evaluation in Radium-223 Treated Castration Resistant Prostate Cancer Patients With Bone Metastases |
https://ClinicalTrials.gov/show/NCT02398526 |
Active, not recruiting |
Bayer |
2020-05-20 |
| NCT02394223 |
FFOCT for the Diagnosis of Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02394223 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2017-01-27 |
| NCT02388308 |
Evaluation of Clarity Ultrasound Guidance for Prostate Therapy |
https://ClinicalTrials.gov/show/NCT02388308 |
Completed |
Institute of Cancer Research, United Kingdom |
2018-06-18 |
| NCT02366494 |
Micro RNAs to Predict Response to Androgen Deprivation Therapy |
https://ClinicalTrials.gov/show/NCT02366494 |
Recruiting |
Medical College of Wisconsin |
2021-02-28 |
| NCT02365883 |
Transrectal Photoacoustic Imaging of the Prostate |
https://ClinicalTrials.gov/show/NCT02365883 |
Active, not recruiting |
Stanford University |
2016-12-20 |
| NCT02362620 |
PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel. |
https://ClinicalTrials.gov/show/NCT02362620 |
Active, not recruiting |
Centro Nacional de Investigaciones Oncologicas CARLOS III |
2018-04-30 |
| NCT02364531 |
A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting |
https://ClinicalTrials.gov/show/NCT02364531 |
Completed |
Janssen Inc. |
2018-11-01 |
| NCT02353715 |
Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing |
https://ClinicalTrials.gov/show/NCT02353715 |
Completed |
Duke University |
2018-11-14 |
| NCT02313623 |
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research |
https://ClinicalTrials.gov/show/NCT02313623 |
Recruiting |
Yale University |
2022-10-31 |
| NCT02274350 |
The Herlev Hospital Post Radiation Therapy for Localized Prostate Cancer Database for Sexual Side Effects |
https://ClinicalTrials.gov/show/NCT02274350 |
Completed |
Herlev Hospital |
2015-10-31 |
| NCT02264379 |
Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma |
https://ClinicalTrials.gov/show/NCT02264379 |
Active, not recruiting |
Technische Universität Dresden |
2020-10-31 |
| NCT02243033 |
Phase II Laser Focal Therapy of Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02243033 |
Recruiting |
Desert Medical Imaging |
2036-05-31 |
| NCT02236637 |
A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical Care |
https://ClinicalTrials.gov/show/NCT02236637 |
Completed |
Janssen Pharmaceutica N.V., Belgium |
2018-11-21 |
| NCT02238366 |
Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02238366 |
Completed |
Ipsen |
2019-06-06 |
| NCT02234089 |
Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists. |
https://ClinicalTrials.gov/show/NCT02234089 |
Completed |
Ferring Pharmaceuticals |
2019-06-30 |
| NCT02230059 |
Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC) |
https://ClinicalTrials.gov/show/NCT02230059 |
Completed |
Janssen Research & Development, LLC |
2014-05-31 |
| NCT02237170 |
Immune Monitoring on Sipuleucel-T |
https://ClinicalTrials.gov/show/NCT02237170 |
Completed |
Icahn School of Medicine at Mount Sinai |
2016-12-31 |
| NCT02232230 |
A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T |
https://ClinicalTrials.gov/show/NCT02232230 |
Completed |
21st Century Oncology |
2018-06-05 |
| NCT02229253 |
Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02229253 |
Completed |
Ferring Pharmaceuticals |
2017-10-04 |
| NCT02228265 |
Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide |
https://ClinicalTrials.gov/show/NCT02228265 |
Active, not recruiting |
OHSU Knight Cancer Institute |
2019-10-01 |
| NCT02224911 |
Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02224911 |
Completed |
Jonsson Comprehensive Cancer Center |
2019-10-21 |
| NCT02189486 |
Prostate Cancer Upgrading Reference Set |
https://ClinicalTrials.gov/show/NCT02189486 |
Recruiting |
The University of Texas Health Science Center at San Antonio |
2021-03-31 |
| NCT02186925 |
A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. |
https://ClinicalTrials.gov/show/NCT02186925 |
Recruiting |
Meir Medical Center |
2019-08-31 |
| NCT02186444 |
Navigator Guided e-Psychoeducational Intervention |
https://ClinicalTrials.gov/show/NCT02186444 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2016-12-30 |
| NCT01325506 |
Effectiveness of Open and Robotic Prostatectomy |
https://ClinicalTrials.gov/show/NCT01325506 |
Active, not recruiting |
Dana-Farber Cancer Institute |
2024-02-29 |
| NCT02167893 |
Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey “Long-term Use Survey in Prostate Cancer Patients (96 Weeks)” |
https://ClinicalTrials.gov/show/NCT02167893 |
Completed |
Takeda |
2010-12-31 |
| NCT02155998 |
Non-Interventional Study PREVENT |
https://ClinicalTrials.gov/show/NCT02155998 |
Completed |
AstraZeneca |
2016-12-14 |
| NCT02151097 |
PRIME - PRostate Imaging for Margin Evaluation |
https://ClinicalTrials.gov/show/NCT02151097 |
Completed |
Lightpoint Medical Limited |
2016-06-30 |
| NCT02141438 |
Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02141438 |
Active, not recruiting |
Bayer |
2024-12-31 |
| NCT02135653 |
A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02135653 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2018-05-24 |
| NCT02128334 |
An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation |
https://ClinicalTrials.gov/show/NCT02128334 |
Completed |
Astellas Pharma Inc |
2016-03-31 |
| NCT02110667 |
Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy |
https://ClinicalTrials.gov/show/NCT02110667 |
Completed |
University of Vermont Medical Center |
2016-01-31 |
| NCT02111954 |
Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer Patients |
https://ClinicalTrials.gov/show/NCT02111954 |
Completed |
University of Lausanne Hospitals |
2016-10-28 |
| NCT02088164 |
Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men |
https://ClinicalTrials.gov/show/NCT02088164 |
Completed |
National Taiwan University Hospital |
2012-04-30 |
| NCT02070575 |
Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence |
https://ClinicalTrials.gov/show/NCT02070575 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-02-28 |
| NCT02066961 |
A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02066961 |
Completed |
Astellas Pharma Inc |
2019-11-14 |
| NCT01306890 |
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01306890 |
Completed |
Dendreon |
2017-01-17 |
| NCT01303692 |
Comparison of Bone Mineral Loss in Prostate Cancer Patients Who is Receiving GnRH Agonist and -Plus Anti-androgen Agent |
https://ClinicalTrials.gov/show/NCT01303692 |
Completed |
AstraZeneca |
2014-02-28 |
| NCT01284608 |
Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT) |
https://ClinicalTrials.gov/show/NCT01284608 |
Completed |
AstraZeneca |
2012-12-31 |
| NCT01277562 |
Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01277562 |
Completed |
City of Hope Medical Center |
2012-12-31 |
| NCT02034825 |
Multi-site Decision Impact Study for Decipher |
https://ClinicalTrials.gov/show/NCT02034825 |
Completed |
GenomeDx Biosciences Corp |
2015-01-31 |
| NCT02034812 |
Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists |
https://ClinicalTrials.gov/show/NCT02034812 |
Completed |
GenomeDx Biosciences Corp |
2014-07-31 |
| NCT02020876 |
Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations |
https://ClinicalTrials.gov/show/NCT02020876 |
Completed |
GenomeDx Biosciences Corp |
2013-01-31 |
| NCT04240327 |
Marker Driven Selection of Patients for Prostate Biopsy and Management |
https://ClinicalTrials.gov/show/NCT04240327 |
Recruiting |
University of Miami |
2025-06-01 |
| NCT03354416 |
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03354416 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2027-12-31 |
| NCT02013180 |
Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer Detection |
https://ClinicalTrials.gov/show/NCT02013180 |
Completed |
Bagcilar Training and Research Hospital |
2013-01-31 |
| NCT02008058 |
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02008058 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2017-03-31 |
| NCT02003417 |
Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy |
https://ClinicalTrials.gov/show/NCT02003417 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2016-07-31 |
| NCT02001597 |
Intra-operative Trans-rectal Ultrasound Guidance for Robot-assisted Radical Prostatectomy |
https://ClinicalTrials.gov/show/NCT02001597 |
Completed |
University of British Columbia |
2013-11-30 |
| NCT01968538 |
Metabolomic Study for Localized Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01968538 |
Enrolling by invitation |
Georgetown University |
2022-12-31 |
| NCT01961713 |
Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy |
https://ClinicalTrials.gov/show/NCT01961713 |
Recruiting |
Massachusetts General Hospital |
2020-04-30 |
| NCT01960881 |
Evaluation of Diet and Exercise in Prostate Cancer Patients |
https://ClinicalTrials.gov/show/NCT01960881 |
Active, not recruiting |
AbbVie |
2021-07-30 |
| NCT01953640 |
Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy |
https://ClinicalTrials.gov/show/NCT01953640 |
Active, not recruiting |
Mayo Clinic |
2015-12-03 |
| NCT01943500 |
Collection of Blood Specimens for Circulating Tumor Cell Analysis |
https://ClinicalTrials.gov/show/NCT01943500 |
Completed |
Viatar LLC |
2014-01-28 |
| NCT01931644 |
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions |
https://ClinicalTrials.gov/show/NCT01931644 |
Recruiting |
Sanguine Biosciences |
2025-08-31 |
| NCT01915316 |
Measurements Of Zinc Concentration On Specimens Taken During Trans-Perineal Prostate Biopsy |
https://ClinicalTrials.gov/show/NCT01915316 |
Completed |
ProSight |
2014-12-31 |
| NCT01905488 |
Perioperative Changes of Cognitive Function According to Jugular Vein Insufficiency in Robot-assisted Prostatectomy |
https://ClinicalTrials.gov/show/NCT01905488 |
Completed |
Yonsei University |
2009-11-30 |
| NCT01877070 |
Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies |
https://ClinicalTrials.gov/show/NCT01877070 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-06-30 |
| NCT01857908 |
A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With Abiraterone |
https://ClinicalTrials.gov/show/NCT01857908 |
Completed |
University Health Network, Toronto |
2014-11-30 |
| NCT01834001 |
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy |
https://ClinicalTrials.gov/show/NCT01834001 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2025-02-25 |
| NCT01813097 |
Combination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01813097 |
Completed |
Chinese PLA General Hospital |
2013-03-31 |
| NCT01810627 |
Application of Megavoltage Imaging to Reduce Artifact After Seed Implants |
https://ClinicalTrials.gov/show/NCT01810627 |
Completed |
University of Kentucky |
2016-04-30 |
| NCT01793077 |
Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer Patients |
https://ClinicalTrials.gov/show/NCT01793077 |
Completed |
Astellas Pharma Inc |
2013-12-31 |
| NCT01780701 |
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01780701 |
Completed |
OHSU Knight Cancer Institute |
2016-01-31 |
| NCT01767363 |
WEUSKOP5723: Prostate Cancer Study |
https://ClinicalTrials.gov/show/NCT01767363 |
Completed |
GlaxoSmithKline |
2016-03-31 |
| NCT01766492 |
Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery |
https://ClinicalTrials.gov/show/NCT01766492 |
Recruiting |
Georgetown University |
2020-04-30 |
| NCT01742962 |
Prevalence of Neglected Side Effects to Radical Prostatectomy |
https://ClinicalTrials.gov/show/NCT01742962 |
Completed |
Copenhagen University Hospital at Herlev |
2013-07-31 |
| NCT01737242 |
UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies |
https://ClinicalTrials.gov/show/NCT01737242 |
Recruiting |
Institute of Cancer Research, United Kingdom |
2022-12-31 |
| NCT01729676 |
Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation |
https://ClinicalTrials.gov/show/NCT01729676 |
Completed |
Ferring Pharmaceuticals |
2014-05-31 |
| NCT01710098 |
Treatment of Prostate Cancer With Firmagon® |
https://ClinicalTrials.gov/show/NCT01710098 |
Completed |
United Clinic Management GmbH |
2014-06-30 |
| NCT01673581 |
Shared Decision Making in Low Risk Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01673581 |
Active, not recruiting |
Massachusetts General Hospital |
2015-12-31 |
| NCT01672905 |
PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802 |
https://ClinicalTrials.gov/show/NCT01672905 |
Completed |
Eastern Cooperative Oncology Group |
2013-01-07 |
| NCT01672411 |
Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01672411 |
Completed |
University Of Perugia |
2012-12-31 |
| NCT01640262 |
Evaluation of Modern MRI in the Diagnosis of Prostate Cancer in a Danish Setup |
https://ClinicalTrials.gov/show/NCT01640262 |
Completed |
Copenhagen University Hospital at Herlev |
2014-08-31 |
| NCT01621425 |
Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity |
https://ClinicalTrials.gov/show/NCT01621425 |
Completed |
Radboud University |
2015-05-31 |
| NCT01614548 |
Management of Prostate Cancer in Central China |
https://ClinicalTrials.gov/show/NCT01614548 |
Completed |
Zhengzhou University |
2011-12-31 |
| NCT01599182 |
Metabolic Effects of Treatment in Intermediate and High-Risk Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01599182 |
Completed |
University of Waterloo |
2014-12-31 |
| NCT01594502 |
Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies |
https://ClinicalTrials.gov/show/NCT01594502 |
Active, not recruiting |
University of Illinois at Chicago |
2019-11-30 |
| NCT01577836 |
Medico-economic Comparison of Robot-assisted Radical Prostatectomy Versus Radical Prostatectomy Via Laparotomy |
https://ClinicalTrials.gov/show/NCT01577836 |
Active, not recruiting |
Centre Hospitalier Universitaire de NÄ«mes |
2019-09-30 |
| NCT01574846 |
Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01574846 |
Completed |
Orion Corporation, Orion Pharma |
2014-04-30 |
| NCT01560858 |
Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant State |
https://ClinicalTrials.gov/show/NCT01560858 |
Completed |
Ipsen |
2013-05-31 |
| NCT01535898 |
Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers |
https://ClinicalTrials.gov/show/NCT01535898 |
Completed |
Memorial Sloan Kettering Cancer Center |
2015-02-28 |
| NCT01529086 |
For Cause Prostate Biopsy in REDUCE Population Trial |
https://ClinicalTrials.gov/show/NCT01529086 |
Completed |
The Cleveland Clinic |
2012-02-29 |
| NCT01545154 |
The Use of Transperineal Ultrasound for Radiation Therapy Treatment Planning and Image Guidance in the Treatment of Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01545154 |
Completed |
University of Vermont Medical Center |
2013-10-31 |
| NCT01525914 |
Response of Patients on Surveillance for Prostate Cancer to Dutasteride |
https://ClinicalTrials.gov/show/NCT01525914 |
Completed |
Sunnybrook Health Sciences Centre |
2010-08-31 |
| NCT01516866 |
Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy |
https://ClinicalTrials.gov/show/NCT01516866 |
Completed |
University of Wisconsin, Madison |
2015-09-30 |
| NCT01514669 |
Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01514669 |
Active, not recruiting |
University of Arkansas |
2021-02-28 |
| NCT01501630 |
Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01501630 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2014-12-31 |
| NCT01499381 |
EMBRACE1: Prostate Biorepository |
https://ClinicalTrials.gov/show/NCT01499381 |
Completed |
Caris Science, Inc. |
2012-07-31 |
| NCT01492751 |
Effectiveness of Localized Prostate Cancer Treatments |
https://ClinicalTrials.gov/show/NCT01492751 |
Active, not recruiting |
Fundacion IMIM |
2015-05-31 |
| NCT03914391 |
To Identify Potential New Urine Markers for the Screening of Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03914391 |
Recruiting |
Chinese University of Hong Kong |
2023-12-31 |
| NCT01464216 |
MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness |
https://ClinicalTrials.gov/show/NCT01464216 |
Recruiting |
Oslo University Hospital |
2016-12-31 |
| NCT01447186 |
Adaptation of the American Cancer Society (ACS) Early Detection of Prostate Cancer Patient Decision Aid for Spanish Speaking Men |
https://ClinicalTrials.gov/show/NCT01447186 |
Completed |
M.D. Anderson Cancer Center |
2015-01-13 |
| NCT01444456 |
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia |
https://ClinicalTrials.gov/show/NCT01444456 |
Completed |
Amgen |
2013-08-31 |
| NCT01441713 |
Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01441713 |
Completed |
Copenhagen University Hospital at Herlev |
2012-05-31 |
| NCT01418040 |
PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) |
https://ClinicalTrials.gov/show/NCT01418040 |
Completed |
Calvary Mater Newcastle, Australia |
2017-07-20 |
| NCT01401972 |
Conventional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer Patients |
https://ClinicalTrials.gov/show/NCT01401972 |
Completed |
Sunnybrook Health Sciences Centre |
2018-09-30 |
| NCT01386684 |
Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study |
https://ClinicalTrials.gov/show/NCT01386684 |
Completed |
AbbVie |
2016-09-08 |
| NCT01379872 |
Assessment of New Radiation Oncology Technologies and Treatments |
https://ClinicalTrials.gov/show/NCT01379872 |
Completed |
Trans-Tasman Radiation Oncology Group (TROG) |
2012-05-31 |
| NCT01383863 |
A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01383863 |
Completed |
Ipsen |
2014-05-31 |
| NCT01376674 |
T-cell-immunity During Standard Radiotherapy in Localised Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01376674 |
Completed |
University Hospital Tuebingen |
NA |
| NCT01371513 |
Korean Practice Patterns for Screening PCA(Prostate Cancer) |
https://ClinicalTrials.gov/show/NCT01371513 |
Completed |
GlaxoSmithKline |
2011-06-30 |
| NCT01366053 |
Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists |
https://ClinicalTrials.gov/show/NCT01366053 |
Completed |
CMX Research |
2015-07-31 |
| NCT01347476 |
Aggressive Prostate Cancers in Elderly Patients |
https://ClinicalTrials.gov/show/NCT01347476 |
Completed |
Seoul National University Hospital |
2010-10-31 |
| NCT01337258 |
Economic Analyses of the REDUCE Trial |
https://ClinicalTrials.gov/show/NCT01337258 |
Completed |
GlaxoSmithKline |
2010-07-31 |
| NCT01320735 |
Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Leuprorelin (Lucrin Depot) in Patients With Advanced Prostate Cancer (PCa) in Russia |
https://ClinicalTrials.gov/show/NCT01320735 |
Completed |
AbbVie |
2014-05-31 |
| NCT04421781 |
Salvage HIFU for Local Recurrence in the Prostatic Bed After Prostatectomy and External Beam Radiation Therapy : Preliminary Results |
https://ClinicalTrials.gov/show/NCT04421781 |
Completed |
Hospices Civils de Lyon |
2020-04-01 |
| NCT04398173 |
Detection Rate of Prostate Cancer in Men Undergoing MRI |
https://ClinicalTrials.gov/show/NCT04398173 |
Active, not recruiting |
Fondazione del Piemonte per l’Oncologia |
2020-10-31 |
| NCT04357717 |
ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting |
https://ClinicalTrials.gov/show/NCT04357717 |
Recruiting |
Exosome Diagnostics, Inc. |
2020-08-31 |
| NCT04341324 |
Effect of ADT in Chinese Male With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT04341324 |
Completed |
Chinese University of Hong Kong |
2019-12-04 |
| NCT04321187 |
Influence of Prostate Cancer Radiation on Aging |
https://ClinicalTrials.gov/show/NCT04321187 |
Recruiting |
Medical University of Graz |
2021-08-31 |
| NCT04298112 |
PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment |
https://ClinicalTrials.gov/show/NCT04298112 |
Recruiting |
Norwegian University of Science and Technology |
2023-05-31 |
| NCT04299997 |
Evaluation of the PI-RADS v2.1 Score Using Multiple Readers |
https://ClinicalTrials.gov/show/NCT04299997 |
Active, not recruiting |
Hospices Civils de Lyon |
2020-01-31 |
| NCT04281147 |
Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the Body |
https://ClinicalTrials.gov/show/NCT04281147 |
Recruiting |
Bayer |
2020-10-01 |
| NCT04268628 |
A Study of Pharmacodynamic and Genetic Parameters of Abira-DES Study Participants (NCT02217566) - Participants With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Following Unresponsive Treatment With Diethylstilbestrol |
https://ClinicalTrials.gov/show/NCT04268628 |
Recruiting |
Janssen-Cilag Farmaceutica Ltda. |
2020-10-05 |
| NCT04256993 |
PRECISE, a Study to Gather More Information About Bone Fractures and Survival in Castration-resistant PRostate Cancer (CRPC) patiEnts Treated With Radium-223 in Routine Clinical practIce in SwedEn |
https://ClinicalTrials.gov/show/NCT04256993 |
Active, not recruiting |
Bayer |
2021-06-01 |
| NCT04254133 |
GIFTS Study for Prostate Cancer |
https://ClinicalTrials.gov/show/NCT04254133 |
Enrolling by invitation |
Fred Hutchinson Cancer Research Center |
2023-08-31 |
| NCT04251546 |
Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined With TPV |
https://ClinicalTrials.gov/show/NCT04251546 |
Recruiting |
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
2021-05-30 |
| NCT04247217 |
Immune Profiling After HDR in Local Relapsed Prostate Cancer |
https://ClinicalTrials.gov/show/NCT04247217 |
Recruiting |
Maastricht Radiation Oncology |
2021-01-01 |
| NCT04219059 |
MR Radiomic Features in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT04219059 |
Recruiting |
IRCCS San Raffaele |
2021-09-06 |
| NCT04193657 |
Toward a Comprehensive Supportive Care Intervention for Older or Frail Men With mCRPC |
https://ClinicalTrials.gov/show/NCT04193657 |
Recruiting |
University Health Network, Toronto |
2021-09-30 |
| NCT04191980 |
Deep Learning for Prostate Segmentation |
https://ClinicalTrials.gov/show/NCT04191980 |
Recruiting |
Hospices Civils de Lyon |
2020-01-31 |
| NCT04189770 |
Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners |
https://ClinicalTrials.gov/show/NCT04189770 |
Recruiting |
M.D. Anderson Cancer Center |
2022-01-01 |
| NCT04188275 |
CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITION |
https://ClinicalTrials.gov/show/NCT04188275 |
Recruiting |
Azienda Ospedaliero-Universitaria Careggi |
2020-06-30 |
| NCT04167722 |
How Does Prostate Cancer Metastasize? Studying the Role of Secreted Packages (Exosomes) From Fat Tissue in Lean and Obese Patients |
https://ClinicalTrials.gov/show/NCT04167722 |
Recruiting |
Imperial College London |
2021-10-01 |
| NCT04124900 |
Telomere Associated Variables (TAVs) in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT04124900 |
Recruiting |
Life Length SL |
2020-11-15 |
| NCT04117594 |
Whole Body Magnetic Resonance Imaging Study |
https://ClinicalTrials.gov/show/NCT04117594 |
Recruiting |
Royal Marsden NHS Foundation Trust |
2021-06-30 |
| NCT04110782 |
Radical Prostatectomy and External Beam Radiotherapy in mCRPC With 223Radium-dicloride (RaProRad) |
https://ClinicalTrials.gov/show/NCT04110782 |
Recruiting |
Azienda Policlinico Umberto I |
2019-06-30 |
| NCT04081428 |
Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT |
https://ClinicalTrials.gov/show/NCT04081428 |
Recruiting |
NHS Lothian |
2019-10-11 |
| NCT04067960 |
Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer |
https://ClinicalTrials.gov/show/NCT04067960 |
Recruiting |
Mayo Clinic |
2020-12-31 |
| NCT04067713 |
Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer |
https://ClinicalTrials.gov/show/NCT04067713 |
Recruiting |
University College, London |
2022-11-28 |
| NCT04057859 |
A Clinical Study in Prostate Cancer Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training |
https://ClinicalTrials.gov/show/NCT04057859 |
Active, not recruiting |
CMX Research |
2019-11-30 |
| NCT04043637 |
Early Urinary Continence After Radical Prostatectomy: Surgical Procedure and Anatomic Landmarks |
https://ClinicalTrials.gov/show/NCT04043637 |
Completed |
Consorci Sanitari Integral |
2018-12-03 |
| NCT04030338 |
Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer |
https://ClinicalTrials.gov/show/NCT04030338 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2022-07-31 |
| NCT04021394 |
Influence of EMT on CTCs and Disease Progression in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT04021394 |
Recruiting |
Lawson Health Research Institute |
2020-09-30 |
| NCT04017325 |
European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up |
https://ClinicalTrials.gov/show/NCT04017325 |
Active, not recruiting |
Steba Biotech S.A. |
2020-06-30 |
| NCT04000776 |
3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer |
https://ClinicalTrials.gov/show/NCT04000776 |
Recruiting |
Université de Sherbrooke |
2021-09-30 |
| NCT03996993 |
Defining Recurrent Disease With Axuminâ„¢ |
https://ClinicalTrials.gov/show/NCT03996993 |
Recruiting |
Cancer Center of Irvine |
2020-09-30 |
| NCT03982706 |
Examination of Focal Therapies- MRI-Fusion, HIFU, NanoKnife and Cryotherapy |
https://ClinicalTrials.gov/show/NCT03982706 |
Enrolling by invitation |
Rabin Medical Center |
2020-06-06 |
| NCT03982095 |
Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03982095 |
Recruiting |
Arcispedale Santa Maria Nuova-IRCCS |
2020-09-30 |
| NCT03979079 |
Modeling Clinical Failure in Prostate Cancer Patients Based on a Two-stage Statistical Model |
https://ClinicalTrials.gov/show/NCT03979079 |
Completed |
Institut Bergonié |
2018-12-31 |
| NCT03967080 |
Adaptive Radiotherapy for High-risk Prostate Cancer Using Multiparametric MRI |
https://ClinicalTrials.gov/show/NCT03967080 |
Recruiting |
East and North Hertfordshire NHS Trust |
2020-03-31 |
| NCT03970863 |
Focal Therapy for Localized Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03970863 |
Recruiting |
China Medical University Hospital |
2019-11-10 |
| NCT03963739 |
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03963739 |
Recruiting |
Wake Forest University Health Sciences |
2021-09-01 |
| NCT03957252 |
Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03957252 |
Recruiting |
Nanostics |
2021-12-31 |
| NCT03948204 |
Quality of Life and Shared Decision Making in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03948204 |
Enrolling by invitation |
Cancer Registry of Norway |
2022-03-31 |
| NCT03927287 |
Prognostic Role of Free Psa Ratio at Biochemical Recurrence After Radical Treatments for Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03927287 |
Completed |
Rabin Medical Center |
2018-12-30 |
| NCT03913039 |
Reduction of Prostate Biopsy Morbidity |
https://ClinicalTrials.gov/show/NCT03913039 |
Recruiting |
Maimonides Medical Center |
2021-04-15 |
| NCT03912883 |
Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting |
https://ClinicalTrials.gov/show/NCT03912883 |
Active, not recruiting |
Queen Mary University of London |
2015-01-31 |
| NCT03911999 |
Exosomal microRNA in Predicting the Aggressiveness of Prostate Cancer in Chinese Patients |
https://ClinicalTrials.gov/show/NCT03911999 |
Recruiting |
Chinese University of Hong Kong |
2021-04-30 |
| NCT03896984 |
Descriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone Therapy or RadIum-223 (Xofigo). |
https://ClinicalTrials.gov/show/NCT03896984 |
Active, not recruiting |
Bayer |
2020-07-31 |
| NCT03896958 |
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) |
https://ClinicalTrials.gov/show/NCT03896958 |
Recruiting |
SpeciCare |
2021-03-12 |
| NCT03893929 |
The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population |
https://ClinicalTrials.gov/show/NCT03893929 |
Recruiting |
Chinese University of Hong Kong |
2025-12-31 |
| NCT03893123 |
Prostate Cancer Risk in Firefighters |
https://ClinicalTrials.gov/show/NCT03893123 |
Active, not recruiting |
Oslo University Hospital |
2020-02-01 |
| NCT03891732 |
MRI Prostate for Chinese Men Being Screened for Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03891732 |
Recruiting |
Chinese University of Hong Kong |
2022-01-31 |
| NCT03888742 |
The Effect of Androgen Deprivation Therapy on Gut and Urinary Microbiota in Patients With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03888742 |
Recruiting |
Chinese University of Hong Kong |
2021-07-31 |
| NCT03867357 |
Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia |
https://ClinicalTrials.gov/show/NCT03867357 |
Recruiting |
Seattle Institute for Biomedical and Clinical Research |
2021-08-31 |
| NCT03857477 |
The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening. |
https://ClinicalTrials.gov/show/NCT03857477 |
Recruiting |
Institute of Cancer Research, United Kingdom |
2020-03-01 |
| NCT03851211 |
Prolaris Enhanced Risk Stratification - an ecONomic and clinicAL Evaluation |
https://ClinicalTrials.gov/show/NCT03851211 |
Recruiting |
The Leeds Teaching Hospitals NHS Trust |
2020-10-30 |
| NCT03805919 |
Men at High Genetic Risk for Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03805919 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2029-01-01 |
| NCT03807492 |
Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR) |
https://ClinicalTrials.gov/show/NCT03807492 |
Recruiting |
Thomas Jefferson University |
2024-01-19 |
| NCT03784924 |
EDRN Prostate MRI Biomarker Study |
https://ClinicalTrials.gov/show/NCT03784924 |
Recruiting |
University of Michigan |
2021-02-04 |
| NCT03783741 |
The Biopsychosocial Burden of Prostate Biopsy |
https://ClinicalTrials.gov/show/NCT03783741 |
Completed |
University of Campinas, Brazil |
2015-01-31 |
| NCT03756077 |
A Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03756077 |
Recruiting |
Wuhan Union Hospital, China |
2019-12-31 |
| NCT03703778 |
Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study) |
https://ClinicalTrials.gov/show/NCT03703778 |
Recruiting |
Chinese University of Hong Kong |
2025-10-31 |
| NCT03707574 |
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study |
https://ClinicalTrials.gov/show/NCT03707574 |
Recruiting |
National Cancer Institute (NCI) |
2023-05-01 |
| NCT03702439 |
Prostate Cancer Screening Trial Using Imaging |
https://ClinicalTrials.gov/show/NCT03702439 |
Completed |
Imperial College London |
2019-05-15 |
| NCT03694483 |
Prostasomes as Diagnostic Tool for Prostate Cancer Detection |
https://ClinicalTrials.gov/show/NCT03694483 |
Recruiting |
Hackensack Meridian Health |
2023-10-01 |
| NCT03692585 |
Ethnographic Study of the Everyday Life of Men With Prostate Cancer, Focusing on Diet, Activities and Digital Behavior |
https://ClinicalTrials.gov/show/NCT03692585 |
Completed |
Danish Cancer Society |
2016-04-30 |
| NCT03692104 |
US-CT Fusion for Post Implant Dosimetry |
https://ClinicalTrials.gov/show/NCT03692104 |
Completed |
British Columbia Cancer Agency |
2018-02-28 |
| NCT03692000 |
Designing a Digital Tool to Support Healthy Lifestyle in Men With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03692000 |
Active, not recruiting |
Danish Cancer Society |
2018-10-01 |
| NCT03687918 |
External Validation of Prostate MRI QCAD/Lyon |
https://ClinicalTrials.gov/show/NCT03687918 |
Recruiting |
Hospices Civils de Lyon |
2018-09-30 |
| NCT03679819 |
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03679819 |
Recruiting |
Institut Paoli-Calmettes |
2021-04-30 |
| NCT03677414 |
Analysis of Androgene Receptors Axis and DNA Damage Repair Genes in Patients With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03677414 |
Active, not recruiting |
Medical University of Graz |
2021-01-31 |
| NCT03677076 |
Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03677076 |
Recruiting |
Medical University of South Carolina |
2020-12-29 |
| NCT03656822 |
Data Visualization of Kidney and Prostate Tumors Using Routine Pre-Operative Imaging, 3D Printed, and 3D Virtual Reality Models |
https://ClinicalTrials.gov/show/NCT03656822 |
Completed |
NYU Langone Health |
2019-12-31 |
| NCT03650946 |
Clinical Application of 68Ga-PSMA PET in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03650946 |
Recruiting |
National Taiwan University Hospital |
2019-07-31 |
| NCT03630926 |
Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones. |
https://ClinicalTrials.gov/show/NCT03630926 |
Active, not recruiting |
Intermountain Health Care, Inc. |
2019-08-31 |
| NCT03620786 |
HIFU for Focal Ablation of Prostate Tissue: An Observational Study |
https://ClinicalTrials.gov/show/NCT03620786 |
Enrolling by invitation |
University of California, Los Angeles |
2021-12-31 |
| NCT03615599 |
Plant-based Diets and Risk of Cancer in the Adventist Health Study-2 |
https://ClinicalTrials.gov/show/NCT03615599 |
Active, not recruiting |
Loma Linda University |
2013-12-31 |
| NCT03615131 |
Accuracy of mpMRI and MRI-targeted, Ultrasound-navigated Prostate Fusion Biopsy in Detection of Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03615131 |
Completed |
Kantonsspital Winterthur KSW |
2017-03-30 |
| NCT03609736 |
PSMA-based 18F-DCFPyL PET/CT: Evaluating Its Application in Real Life |
https://ClinicalTrials.gov/show/NCT03609736 |
Recruiting |
Grand River Hospital |
2019-08-31 |
| NCT03611686 |
Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies |
https://ClinicalTrials.gov/show/NCT03611686 |
Recruiting |
University Hospital, Rouen |
2026-04-30 |
| NCT00836238 |
Questionnaire and Fall Risk Assessment |
https://ClinicalTrials.gov/show/NCT00836238 |
Completed |
M.D. Anderson Cancer Center |
2009-06-30 |
| NCT03601143 |
Liquid Biopsy-based Detection of Resistance to Targeted Therapy in Prostate Cancer Patients |
https://ClinicalTrials.gov/show/NCT03601143 |
Recruiting |
Technische Universität München |
2021-11-01 |
| NCT03579680 |
De-implementation of Low Value Castration for Men With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03579680 |
Recruiting |
University of Michigan |
2021-06-30 |
| NCT03565289 |
PRospective Prostate biOmarker Study |
https://ClinicalTrials.gov/show/NCT03565289 |
Active, not recruiting |
ProteoMediX AG |
2019-12-31 |
| NCT03563014 |
A Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223 |
https://ClinicalTrials.gov/show/NCT03563014 |
Completed |
Bayer |
2019-01-31 |
| NCT03535987 |
Pilot Cohort Study of Rb-82 Myocardial PET Imaging to Evaluate Coronary Microvascular Dysfunction in Men With Prostate Cancer Receiving Androgen-Deprivation Therapy |
https://ClinicalTrials.gov/show/NCT03535987 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2019-04-19 |
| NCT03511235 |
Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing |
https://ClinicalTrials.gov/show/NCT03511235 |
Completed |
Myriad Genetic Laboratories, Inc. |
2018-07-31 |
| NCT03503643 |
Hemi-Gland Cryoablation for Prostate Cancer at UCLA |
https://ClinicalTrials.gov/show/NCT03503643 |
Enrolling by invitation |
University of California, Los Angeles |
2021-12-31 |
| NCT03501173 |
A Study of Participants With Advanced Prostate Cancer in Canada |
https://ClinicalTrials.gov/show/NCT03501173 |
Recruiting |
Janssen Inc. |
2021-04-30 |
| NCT03502213 |
A Real World Study In Urology Practices Looking At The Impact Of The OncotypeDX GPS Test On Men Choosing And Remaining On Active Surveillance |
https://ClinicalTrials.gov/show/NCT03502213 |
Completed |
Genomic Health®, Inc. |
2018-06-30 |
| NCT03503097 |
Genetic Testing for Men With Metastatic Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03503097 |
Recruiting |
University of Washington |
2021-08-21 |
| NCT03494803 |
Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC |
https://ClinicalTrials.gov/show/NCT03494803 |
Recruiting |
HKGepitherapeutics |
2021-12-01 |
| NCT03485794 |
Collection of Blood in Studying Metabolites in Patients With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03485794 |
Recruiting |
University of Southern California |
2020-11-14 |
| NCT03488706 |
Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level |
https://ClinicalTrials.gov/show/NCT03488706 |
Recruiting |
CellMaxLife |
2018-12-12 |
| NCT03475433 |
An Observational Prospective Cohort Study Using an Actigraphy Device. |
https://ClinicalTrials.gov/show/NCT03475433 |
Completed |
Taipei Medical University |
2018-07-31 |
| NCT03474913 |
Upright MRI for Prostate Cancer Screening |
https://ClinicalTrials.gov/show/NCT03474913 |
Recruiting |
Icahn School of Medicine at Mount Sinai |
2024-08-01 |
| NCT03442075 |
Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Biopsy |
https://ClinicalTrials.gov/show/NCT03442075 |
Completed |
Instituto Mexicano del Seguro Social |
2017-07-31 |
| NCT03424213 |
Race-related Alternative Splicing: Novel Targets in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03424213 |
Recruiting |
Duke University |
2020-12-31 |
| NCT03421015 |
Genetic Analysis of Prostate Cancer to Identify Predictive Markers of Disease Relapse or Metastatic Evolution |
https://ClinicalTrials.gov/show/NCT03421015 |
Recruiting |
University Hospital, Lille |
2020-07-31 |
| NCT03414437 |
Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303) |
https://ClinicalTrials.gov/show/NCT03414437 |
Active, not recruiting |
Carolina Research Professionals, LLC |
2021-10-01 |
| NCT03419442 |
Multi-academic Center Study of Xofigo Patients |
https://ClinicalTrials.gov/show/NCT03419442 |
Completed |
Bayer |
2019-10-22 |
| NCT03413007 |
Correlation Between iXip and Final Pathology Specimen From Radical Prostatectomy: a Multicenter Prospective Trial |
https://ClinicalTrials.gov/show/NCT03413007 |
Recruiting |
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia |
2018-10-31 |
| NCT01234350 |
A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON |
https://ClinicalTrials.gov/show/NCT01234350 |
Completed |
Ferring Pharmaceuticals |
2018-03-27 |
| NCT01233557 |
Biomarkers of Bone Resorption in Metastatic Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01233557 |
Completed |
University of Aberdeen |
2014-08-31 |
| NCT01226004 |
Multi-Institutional Registry for Prostate Cancer Radiosurgery |
https://ClinicalTrials.gov/show/NCT01226004 |
Recruiting |
Florida Robotic Radiosurgery Association |
2020-07-31 |
| NCT01215526 |
A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01215526 |
Completed |
Ferring Pharmaceuticals |
2015-07-31 |
| NCT01198457 |
Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment |
https://ClinicalTrials.gov/show/NCT01198457 |
Completed |
Bayer |
2010-06-30 |
| NCT01191099 |
Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic Significance |
https://ClinicalTrials.gov/show/NCT01191099 |
Recruiting |
University of Zurich |
2012-08-31 |
| NCT01191931 |
Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02) |
https://ClinicalTrials.gov/show/NCT01191931 |
Completed |
Advanced Medical Diagnostics s.a. |
NA |
| NCT01176526 |
The Role of Social Comparisons in Coping and Quality of Life Following a Prostate Cancer Diagnosis |
https://ClinicalTrials.gov/show/NCT01176526 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01160705 |
Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2 |
https://ClinicalTrials.gov/show/NCT01160705 |
Active, not recruiting |
Cancer Trials Ireland |
2017-09-19 |
| NCT01123434 |
Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients. |
https://ClinicalTrials.gov/show/NCT01123434 |
Completed |
AstraZeneca |
2014-08-31 |
| NCT01120262 |
S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin |
https://ClinicalTrials.gov/show/NCT01120262 |
Completed |
Southwest Oncology Group |
2010-07-31 |
| NCT01098552 |
Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up |
https://ClinicalTrials.gov/show/NCT01098552 |
Completed |
Mayo Clinic |
2012-11-30 |
| NCT01081873 |
Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01081873 |
Completed |
Abbott |
2010-12-31 |
| NCT01078545 |
Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS) |
https://ClinicalTrials.gov/show/NCT01078545 |
Completed |
Abbott |
2010-11-30 |
| NCT01062503 |
Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC |
https://ClinicalTrials.gov/show/NCT01062503 |
Completed |
University Health Network, Toronto |
2014-06-30 |
| NCT01056562 |
An Alternative to A Fixed Schedule In Management Of Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01056562 |
Completed |
University Health Network, Toronto |
2014-06-30 |
| NCT01025479 |
Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen Agent |
https://ClinicalTrials.gov/show/NCT01025479 |
Completed |
AstraZeneca |
2010-03-31 |
| NCT01023529 |
Symptoms and Quality of Life (QoL) After Palliative Pelvic Radiation of Prostate and Rectal Cancers |
https://ClinicalTrials.gov/show/NCT01023529 |
Completed |
Sorlandet Hospital HF |
2015-07-31 |
| NCT01020604 |
PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients |
https://ClinicalTrials.gov/show/NCT01020604 |
Completed |
AstraZeneca |
2013-03-31 |
| NCT01013025 |
Vantas Implant Retrieval Study |
https://ClinicalTrials.gov/show/NCT01013025 |
Completed |
Endo Pharmaceuticals |
2007-06-30 |
| NCT01005225 |
Genetic Investigation of Solid Tumors Cohort |
https://ClinicalTrials.gov/show/NCT01005225 |
Completed |
Scripps Translational Science Institute |
2014-05-31 |
| NCT00992251 |
Eligard Observational Registry for Patients With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00992251 |
Completed |
CMX Research |
2014-03-31 |
| NCT00991315 |
Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate |
https://ClinicalTrials.gov/show/NCT00991315 |
Active, not recruiting |
Rutgers, The State University of New Jersey |
2021-05-31 |
| NCT00984919 |
Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00984919 |
Completed |
Barbara Ann Karmanos Cancer Institute |
2011-01-31 |
| NCT00955435 |
Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15 |
https://ClinicalTrials.gov/show/NCT00955435 |
Active, not recruiting |
Cancer Trials Ireland |
2012-10-31 |
| NCT00949819 |
Active Surveillance for Cancer of the Prostate (ASCaP) |
https://ClinicalTrials.gov/show/NCT00949819 |
Recruiting |
Jonsson Comprehensive Cancer Center |
2020-06-04 |
| NCT00937586 |
Prostate Cancer Prospective Cohort |
https://ClinicalTrials.gov/show/NCT00937586 |
Active, not recruiting |
Washington University School of Medicine |
2025-06-30 |
| NCT00930319 |
Effectiveness and Safety of Firmagon® |
https://ClinicalTrials.gov/show/NCT00930319 |
Completed |
Ferring Pharmaceuticals |
2013-12-31 |
| NCT00923416 |
Trans-Rectal Ultrasound-Guided (TRUS) Adverse Events |
https://ClinicalTrials.gov/show/NCT00923416 |
Completed |
University Health Network, Toronto |
2010-11-30 |
| NCT00923221 |
Collection of Blood From Patients With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00923221 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00923104 |
An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin |
https://ClinicalTrials.gov/show/NCT00923104 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00919477 |
Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg |
https://ClinicalTrials.gov/show/NCT00919477 |
Completed |
AstraZeneca |
2012-03-31 |
| NCT00908674 |
Androcur Effects on Quality of Life |
https://ClinicalTrials.gov/show/NCT00908674 |
Completed |
Bayer |
2010-01-31 |
| NCT00905086 |
Psychosocial Adjustment After Radiation Therapy in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00905086 |
Completed |
Case Comprehensive Cancer Center |
2009-02-28 |
| NCT00900185 |
Study of a Polymorphism in Patients With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00900185 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00899912 |
Changes in DNA After Radiation Therapy in Patients With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00899912 |
Completed |
Radiation Therapy Oncology Group |
2013-11-30 |
| NCT00898326 |
PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00898326 |
Completed |
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan |
2016-12-31 |
| NCT00899665 |
Proteases in Patients With Prostate Cancer That Has Spread to the Bone |
https://ClinicalTrials.gov/show/NCT00899665 |
Completed |
Barbara Ann Karmanos Cancer Institute |
2006-09-30 |
| NCT00899184 |
DNA Changes in Patients With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00899184 |
Completed |
Eastern Cooperative Oncology Group |
2007-05-30 |
| NCT00898274 |
Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants |
https://ClinicalTrials.gov/show/NCT00898274 |
Completed |
Case Comprehensive Cancer Center |
2011-05-31 |
| NCT00897793 |
Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer |
https://ClinicalTrials.gov/show/NCT00897793 |
Completed |
Vanderbilt-Ingram Cancer Center |
2010-07-31 |
| NCT00897351 |
Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803 |
https://ClinicalTrials.gov/show/NCT00897351 |
Completed |
Eastern Cooperative Oncology Group |
2009-02-10 |
| NCT00893035 |
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients |
https://ClinicalTrials.gov/show/NCT00893035 |
Active, not recruiting |
Institut du Cancer de Montpellier - Val d’Aurelle |
2015-12-31 |
| NCT00883909 |
ARI103094-Follow-Up Study for REDUCE Study Subjects |
https://ClinicalTrials.gov/show/NCT00883909 |
Completed |
GlaxoSmithKline |
2010-12-01 |
| NCT00874211 |
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases |
https://ClinicalTrials.gov/show/NCT00874211 |
Completed |
Southwest Oncology Group |
2019-06-30 |
| NCT00871585 |
Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide |
https://ClinicalTrials.gov/show/NCT00871585 |
Completed |
AstraZeneca |
2010-01-31 |
| NCT00868803 |
Aberrant Gene Expression Prostate Carcinoma |
https://ClinicalTrials.gov/show/NCT00868803 |
Active, not recruiting |
Lahey Clinic |
2020-04-30 |
| NCT00850941 |
Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy |
https://ClinicalTrials.gov/show/NCT00850941 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-01-31 |
| NCT04102904 |
The Prostate Liquid Study (PLiS) |
https://ClinicalTrials.gov/show/NCT04102904 |
Recruiting |
University College, London |
2021-03-31 |
| NCT03871816 |
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03871816 |
Recruiting |
Janssen Research & Development, LLC |
2021-07-26 |
| NCT03241758 |
Vascular Changes Of Patients Undergoing Laparoscopic Radical Prostatectomy |
https://ClinicalTrials.gov/show/NCT03241758 |
Completed |
Corporacion Parc Tauli |
2017-08-02 |
| NCT00828633 |
Health-Related Quality of Life in Gay Men With Localized Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00828633 |
Completed |
Baylor College of Medicine |
2010-12-31 |
| NCT00831142 |
Characterization of Prostate Cancer With 3T MR |
https://ClinicalTrials.gov/show/NCT00831142 |
Active, not recruiting |
Beth Israel Deaconess Medical Center |
2012-01-31 |
| NCT00822952 |
Prostate Mechanical Imager (PMI) Clinical Bridging Study |
https://ClinicalTrials.gov/show/NCT00822952 |
Completed |
Artann Laboratories |
2009-09-30 |
| NCT04017104 |
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging |
https://ClinicalTrials.gov/show/NCT04017104 |
Recruiting |
British Columbia Cancer Agency |
2022-08-01 |
| NCT04122976 |
A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described |
https://ClinicalTrials.gov/show/NCT04122976 |
Recruiting |
Bayer |
2025-01-30 |
| NCT03604211 |
SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience |
https://ClinicalTrials.gov/show/NCT03604211 |
Completed |
Kantonsspital Graubuenden |
2015-07-31 |
| NCT03451812 |
Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03451812 |
Recruiting |
Chang Gung Memorial Hospital |
2019-12-31 |
| NCT03232411 |
Biobank for African American Prostate Cancer Research in Florida |
https://ClinicalTrials.gov/show/NCT03232411 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2020-12-31 |
| NCT02269982 |
Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY |
https://ClinicalTrials.gov/show/NCT02269982 |
Completed |
Duke University |
2017-09-01 |
| NCT02450435 |
The Detection of Circulating Tumor Cells (CTCs) in Patients With Prostatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment |
https://ClinicalTrials.gov/show/NCT02450435 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2015-12-31 |
| NCT00811876 |
Retrospective, Non-interventional Study of Depo-Eligard®. |
https://ClinicalTrials.gov/show/NCT00811876 |
Completed |
Astellas Pharma Inc |
2009-12-31 |
| NCT00807820 |
Phase I Targeting Dominant Intraprostatic Lesion Using MR Spectroscopy and HDR Brachytherapy |
https://ClinicalTrials.gov/show/NCT00807820 |
Completed |
University of California, San Francisco |
2011-06-30 |
| NCT03315260 |
Treatment Satisfaction With Ra-223 in Japan |
https://ClinicalTrials.gov/show/NCT03315260 |
Recruiting |
Bayer |
2020-06-30 |
| NCT02594202 |
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue |
https://ClinicalTrials.gov/show/NCT02594202 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2026-01-01 |
| NCT04130776 |
4Kscore Using Serum Stored Uncentrifuged |
https://ClinicalTrials.gov/show/NCT04130776 |
Completed |
OPKO Health, Inc. |
2018-03-27 |
| NCT03851926 |
Hypofraccionated Radiotherapy for Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03851926 |
Recruiting |
Consorci Sanitari de Terrassa |
2021-10-05 |
| NCT03755492 |
Initiative to Minimize Disparities in Postoperative Prostate Cancer Care |
https://ClinicalTrials.gov/show/NCT03755492 |
Recruiting |
Albert Einstein Healthcare Network |
2021-06-30 |
| NCT03289130 |
Dietary Factors and Racial Disparities in Prostate Cancer Aggressiveness |
https://ClinicalTrials.gov/show/NCT03289130 |
Completed |
University of South Carolina |
2009-08-31 |
| NCT02858128 |
WB-DW-MRI vs CHOLINE-PET/CT for Selecting Treatments in Recurrent Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02858128 |
Completed |
Hospital Provincial de Castellon |
2015-03-31 |
| NCT01800058 |
Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone Therapy |
https://ClinicalTrials.gov/show/NCT01800058 |
Completed |
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa |
2018-12-21 |
| NCT01326286 |
Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01326286 |
Completed |
Vanderbilt University Medical Center |
2017-08-31 |
| NCT01428869 |
Combination Statin, Acetylsalicylic Acid and Dutasteride Use in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01428869 |
Completed |
University Health Network, Toronto |
NA |
| NCT04278443 |
Fertility After Prostate Brachytherapy |
https://ClinicalTrials.gov/show/NCT04278443 |
Recruiting |
East and North Hertfordshire NHS Trust |
2021-08-05 |
| NCT04146077 |
Active Surveillance for Low Risk Prostate Cancer |
https://ClinicalTrials.gov/show/NCT04146077 |
Recruiting |
I.M. Sechenov First Moscow State Medical University |
2024-10-31 |
| NCT00816452 |
Awareness to Osteopenia’s Treatment by Bisphosphonate in Male Suffering From Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00816452 |
Completed |
Sanofi |
2010-07-31 |
| NCT00777452 |
A Prospective Longitudinal Study of Health-Related Quality of Life in Men With Clinically Localized Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00777452 |
Completed |
Samsung Medical Center |
2007-12-31 |
| NCT00773656 |
Patients Overexposed for a Prostate Adenocarcinoma |
https://ClinicalTrials.gov/show/NCT00773656 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2013-05-31 |
| NCT00773305 |
Efficacy of Prostate Seed Implantation for Local Control of Early Stage Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00773305 |
Completed |
Summa Health System |
2010-11-30 |
| NCT00769223 |
Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00769223 |
Recruiting |
University of California, San Francisco |
2025-01-31 |
| NCT00800813 |
Change in Penile Length Following Bilateral Nerve-Sparing Radical Prostatectomy |
https://ClinicalTrials.gov/show/NCT00800813 |
Completed |
Memorial Sloan Kettering Cancer Center |
2014-07-31 |
| NCT00763152 |
CMT-07-08: The PROstate Bed Evaluation Study |
https://ClinicalTrials.gov/show/NCT00763152 |
Completed |
Varian Medical |
2009-08-31 |
| NCT00754000 |
The AIM Study: Assessing the Impact of Margin Reduction |
https://ClinicalTrials.gov/show/NCT00754000 |
Completed |
Varian Medical |
NA |
| NCT00756665 |
Prostate Active Surveillance Study |
https://ClinicalTrials.gov/show/NCT00756665 |
Recruiting |
University of Washington |
2024-09-30 |
| NCT00733213 |
Depiction of Prostate Cancer Treatment Alternatives in Greece |
https://ClinicalTrials.gov/show/NCT00733213 |
Completed |
AstraZeneca |
NA |
| NCT00717613 |
Psychosocial and Patient Education Needs of Prostate Cancer Patients Selecting Watchful Waiting |
https://ClinicalTrials.gov/show/NCT00717613 |
Completed |
Baylor College of Medicine |
2009-10-31 |
| NCT00702104 |
Frequency of Prostate-Specific Antigen Screening in African American Men in the San Francisco Area |
https://ClinicalTrials.gov/show/NCT00702104 |
Completed |
University of California, San Francisco |
2008-01-31 |
| NCT00692874 |
Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy |
https://ClinicalTrials.gov/show/NCT00692874 |
Completed |
AstraZeneca |
2010-07-31 |
| NCT00688532 |
Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not |
https://ClinicalTrials.gov/show/NCT00688532 |
Completed |
AstraZeneca |
2009-06-30 |
| NCT00662324 |
Development of a Clinical Trial Specific Question Prompt List |
https://ClinicalTrials.gov/show/NCT00662324 |
Completed |
Memorial Sloan Kettering Cancer Center |
2013-05-31 |
| NCT00651222 |
Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate Brachytherapy |
https://ClinicalTrials.gov/show/NCT00651222 |
Completed |
Prostate Cancer Foundation of Chicago |
NA |
| NCT00636090 |
Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001 |
https://ClinicalTrials.gov/show/NCT00636090 |
Completed |
Duke University |
2009-12-31 |
| NCT00632905 |
Bone Health Observational Study |
https://ClinicalTrials.gov/show/NCT00632905 |
Completed |
CMX Research |
2016-03-31 |
| NCT00590993 |
Magnetic Resonance Imaging and Spectroscopy of the Prostate |
https://ClinicalTrials.gov/show/NCT00590993 |
Completed |
Memorial Sloan Kettering Cancer Center |
2013-02-28 |
| NCT00584792 |
Diet, Genetic Variation and Prostate Cancer Among African Americans |
https://ClinicalTrials.gov/show/NCT00584792 |
Completed |
University of California, Davis |
2007-12-31 |
| NCT00581724 |
Pain in Cancer Survivors |
https://ClinicalTrials.gov/show/NCT00581724 |
Completed |
Memorial Sloan Kettering Cancer Center |
2012-01-31 |
| NCT00581672 |
Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men |
https://ClinicalTrials.gov/show/NCT00581672 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2020-12-31 |
| NCT00581516 |
Molecular Urine Tests for Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00581516 |
Completed |
University of California, Irvine |
2008-09-30 |
| NCT00580476 |
Assessing Depression in a Geriatric Cancer Population |
https://ClinicalTrials.gov/show/NCT00580476 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2020-12-31 |
| NCT00579072 |
The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older |
https://ClinicalTrials.gov/show/NCT00579072 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-12-31 |
| NCT00579163 |
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers |
https://ClinicalTrials.gov/show/NCT00579163 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-12-31 |
| NCT00578409 |
Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data |
https://ClinicalTrials.gov/show/NCT00578409 |
Completed |
Memorial Sloan Kettering Cancer Center |
2010-04-30 |
| NCT00582530 |
Men Undergoing Radical Prostatectomy |
https://ClinicalTrials.gov/show/NCT00582530 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-12-31 |
| NCT00574899 |
Prostate Biomarker Study |
https://ClinicalTrials.gov/show/NCT00574899 |
Completed |
Memorial Sloan Kettering Cancer Center |
2011-05-31 |
| NCT00561444 |
Quality of Life Study for Prostate Cancer Patients |
https://ClinicalTrials.gov/show/NCT00561444 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-11-30 |
| NCT00544336 |
Family Quality of Life Among Families With a Member Who is a Cancer Patient |
https://ClinicalTrials.gov/show/NCT00544336 |
Completed |
Vanderbilt-Ingram Cancer Center |
2009-02-28 |
| NCT00540059 |
Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial |
https://ClinicalTrials.gov/show/NCT00540059 |
Completed |
AstraZeneca |
NA |
| NCT00534196 |
Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00534196 |
Active, not recruiting |
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan |
2016-11-30 |
| NCT00535834 |
Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154 |
https://ClinicalTrials.gov/show/NCT00535834 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00523484 |
Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts |
https://ClinicalTrials.gov/show/NCT00523484 |
Completed |
AstraZeneca |
2008-11-30 |
| NCT00513721 |
Retrospective Study of Positive Biopsy Specimens on Patients Undergoing a Prostatectomy |
https://ClinicalTrials.gov/show/NCT00513721 |
Completed |
William Beaumont Hospitals |
2009-05-31 |
| NCT00507351 |
Ambulatory Cancer Pain Management: A Feasibility Study |
https://ClinicalTrials.gov/show/NCT00507351 |
Completed |
M.D. Anderson Cancer Center |
2009-07-31 |
| NCT00496249 |
The Effect of Radiation on Semen Quality and Fertility in Men With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00496249 |
Completed |
University Health Network, Toronto |
2008-01-31 |
| NCT00499421 |
Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy |
https://ClinicalTrials.gov/show/NCT00499421 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-09-30 |
| NCT00490763 |
Active Surveillance in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00490763 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-02-29 |
| NCT00489814 |
Study of Quality of Life for Prostate Proton Therapy |
https://ClinicalTrials.gov/show/NCT00489814 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-05-24 |
| NCT00456144 |
Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00456144 |
Completed |
Massachusetts General Hospital |
2012-09-30 |
| NCT00455624 |
Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00455624 |
Completed |
Massachusetts General Hospital |
2006-05-31 |
| NCT00453661 |
Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities |
https://ClinicalTrials.gov/show/NCT00453661 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2022-03-31 |
| NCT00444730 |
Urology Database for Outcomes Research |
https://ClinicalTrials.gov/show/NCT00444730 |
Completed |
William Beaumont Hospitals |
2014-08-31 |
| NCT00442000 |
Outcomes Comparison of Robotic, Retropubic, and Perineal Prostatectomy |
https://ClinicalTrials.gov/show/NCT00442000 |
Completed |
William Beaumont Hospitals |
2009-12-31 |
| NCT00433602 |
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors |
https://ClinicalTrials.gov/show/NCT00433602 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2007-03-31 |
| NCT00392938 |
Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone |
https://ClinicalTrials.gov/show/NCT00392938 |
Completed |
University of Washington |
2010-05-31 |
| NCT00339534 |
Survey of Prostate Cancer in Accra, Ghana |
https://ClinicalTrials.gov/show/NCT00339534 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-05-15 |
| NCT00376298 |
Urology Database to Evaluate Clinical Information and Improve Patient Care. |
https://ClinicalTrials.gov/show/NCT00376298 |
Completed |
William Beaumont Hospitals |
2015-12-31 |
| NCT00373308 |
Quality of Life Following Radical Prostatectomy |
https://ClinicalTrials.gov/show/NCT00373308 |
Active, not recruiting |
Stanford University |
2020-07-31 |
| NCT00373035 |
Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy |
https://ClinicalTrials.gov/show/NCT00373035 |
Completed |
Wake Forest University Health Sciences |
2006-07-31 |
| NCT00348465 |
Prostate Volume Changes Following Prostate Brachytherapy With Iodine-125 Seeds |
https://ClinicalTrials.gov/show/NCT00348465 |
Completed |
New York Methodist Hospital |
2007-12-31 |
| NCT00340717 |
Markers for Early Detection of Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00340717 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00335634 |
Sexual Dysfunction and Adaptation in Couples Affected by Prostate Cancer Surgery |
https://ClinicalTrials.gov/show/NCT00335634 |
Completed |
University Health Network, Toronto |
2009-07-31 |
| NCT00323388 |
Identification of Risk Allels for Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00323388 |
Completed |
University of New Mexico |
2007-09-30 |
| NCT00323180 |
Investigation of Protein Biomarkers of Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00323180 |
Completed |
University of New Mexico |
2009-02-28 |
| NCT00303914 |
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT00303914 |
Completed |
Eastern Cooperative Oncology Group |
2008-03-31 |
| NCT00292019 |
Robotic Laparoscopic Radical Prostatectomy |
https://ClinicalTrials.gov/show/NCT00292019 |
Completed |
Lawson Health Research Institute |
2016-06-30 |
| NCT00261456 |
The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer |
https://ClinicalTrials.gov/show/NCT00261456 |
Recruiting |
Institute of Cancer Research, United Kingdom |
2020-02-29 |
| NCT00264017 |
Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs. Twice Daily Dosing of Flomax- A 3 Month Retrospective Efficacy Analysis |
https://ClinicalTrials.gov/show/NCT00264017 |
Completed |
Dattoli Cancer Center and Brachytherapy Research Institute |
NA |
| NCT00252460 |
CT/MRI Co-registration Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00252460 |
Completed |
University Health Network, Toronto |
2010-11-30 |
| NCT00213694 |
PROSTACOX : Metastatic Prostate Chemotherapy |
https://ClinicalTrials.gov/show/NCT00213694 |
Completed |
University Hospital, Rouen |
NA |
| NCT00203918 |
Prostate Cancer Utilities and Cost-Effectiveness Analysis |
https://ClinicalTrials.gov/show/NCT00203918 |
Completed |
University of Chicago |
2011-02-28 |
| NCT00199537 |
Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00199537 |
Completed |
Lawson Health Research Institute |
2008-02-29 |
| NCT00186368 |
Microarray Analysis of Gene Expression in Prostate Tissues |
https://ClinicalTrials.gov/show/NCT00186368 |
Active, not recruiting |
Stanford University |
2021-12-31 |
| NCT00182624 |
Magnetic Resonance Imaging to Evaluate Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00182624 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00176579 |
Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00176579 |
Completed |
Rutgers, The State University of New Jersey |
2008-07-31 |
| NCT00169676 |
Registry and Database Lap Prostatectomy |
https://ClinicalTrials.gov/show/NCT00169676 |
Completed |
Indiana Kidney Stone Institute |
2016-04-30 |
| NCT00126815 |
Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy |
https://ClinicalTrials.gov/show/NCT00126815 |
Completed |
AHS Cancer Control Alberta |
2008-03-31 |
| NCT00124410 |
Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation |
https://ClinicalTrials.gov/show/NCT00124410 |
Completed |
AHS Cancer Control Alberta |
2008-12-31 |
| NCT00087347 |
Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer |
https://ClinicalTrials.gov/show/NCT00087347 |
Completed |
Massachusetts General Hospital |
2006-09-30 |
| NCT00002924 |
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy |
https://ClinicalTrials.gov/show/NCT00002924 |
Completed |
Alliance for Clinical Trials in Oncology |
2006-06-30 |
| NCT00052481 |
Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00052481 |
Completed |
Alliance for Clinical Trials in Oncology |
2004-04-30 |
| NCT00041301 |
Assessing Quality of Life of Patients With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00041301 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2004-12-31 |
| NCT00003329 |
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer |
https://ClinicalTrials.gov/show/NCT00003329 |
Completed |
Eastern Cooperative Oncology Group |
2007-12-31 |
| NCT00001377 |
Familial Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00001377 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00041847 |
Gene-Environment Interaction in Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00041847 |
Completed |
National Institute of Environmental Health Sciences (NIEHS) |
2005-07-31 |
| NCT00035217 |
Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program |
https://ClinicalTrials.gov/show/NCT00035217 |
Completed |
National Center for Research Resources (NCRR) |
NA |
| NCT00582842 |
Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00582842 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-05-31 |
| NCT00668083 |
Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00668083 |
Completed |
AstraZeneca |
2007-10-31 |
| NCT00022919 |
Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods |
https://ClinicalTrials.gov/show/NCT00022919 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00342784 |
Identification of Prostate Cancer Genes |
https://ClinicalTrials.gov/show/NCT00342784 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00007579 |
To Explore Racial Differences in Potential Risk Factors for Developing Prostate Cancer in the VA Population. |
https://ClinicalTrials.gov/show/NCT00007579 |
Completed |
VA Office of Research and Development |
NA |
| NCT00007540 |
Study of Prostate Cancer in Black and White U.S. Veterans |
https://ClinicalTrials.gov/show/NCT00007540 |
Completed |
VA Office of Research and Development |
NA |
| NCT00001469 |
Genetic Analysis of Hereditary Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00001469 |
Completed |
National Institutes of Health Clinical Center (CC) |
2009-07-17 |
| NCT00011349 |
Early Stage Prostate Cancer Cohort |
https://ClinicalTrials.gov/show/NCT00011349 |
Completed |
VA Office of Research and Development |
2006-06-30 |